Clinical-stage Asia-Pacific biopharmaceutical company Antengene (SEHK: 6996) officially listed on the Main Board of The Stock Exchange of Hong Kong Limited on Nov. 20, 2020.
Qiming Venture Partners, a Shangai, China-based venture capital firm, closed Qiming Venture Partners Fund VII, at $1.2 billion.
D3 Bio, a Shangai, China-based global biotechnology company focused on developing and commercializing precision medicines to improve or replace existing standard-of-care treatments that do not fully meet patient needs, launched today with US$200m in Series A financing.
Wuxi Biortus Biosciences Co. Ltd., a Wuxi, China-based leader in structural biology service for drug discovery, closed a US$15m Series A financing.
Zilliz, a Shangai, China-based AI-powered unstructured data analytics startup, closed a $43m Series B funding.
Baidu, Inc. (NASDAQ: BIDU), a search engine, knowledge and information centered Internet platform and AI company, entered into definitive agreements with Joyy, Inc., to acquire its domestic video-based entertainment live streaming business in China (“YY Live”), for an aggregate purchase price of approximately US$3.6 billion in cash, subject to certain adjustments.
Happay, a Chinese BNPL (Buy Now Pay Later) platform, raised USD10M in funding.
ShowPay, a Guangzhou, China-based blockchain enterprise from the Bitcoin SV (BSV) ecosystem, completed a $1.5m angel funding round.
Inceptio Technology, a Shangai, China-based autonomous truck company, raised US$120m in funding.
Inmagene Biopharmaceuticals, a Shangai, China-based drug development company, closed a $21m Series B financing.
Broncus Holding Company, a Hangzhou, China-based global leader in diagnostic and therapeutic technology for lung diseases, closed a Series C round of funding.
CARsgen Therapeutics Holdings Limited, a Shangai, China-based biotechnology company focused on innovation and development of chimeric antigen receptor (CAR) T-cell therapeutics, raised a USD186m in Series C equity financing.
Bits x Bites, an agrifood tech venture capital fund focusing on the Chinese market, raised $30M in the first close of its new $70m fund.
Minieye, a Chinese company that focuses on the development of sensing systems for autonomous driving, completed a 270m RMB Series C financing.
Autohome is to make an investment in TTP Car Inc., an auction platform for used cars in China, through subscription of preferred shares in the capital of the company for an aggregate purchase price of US$168m.